← FDA Drug Approvals (Drugs@FDA)

METHOCARBAMOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2018-04-17

Drug application

FDA Application #

ANDA209331

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHOCARBAMOL

Generic name

METHOCARBAMOL

Active ingredients

METHOCARBAMOL

Dosage form

SOLUTION

Route

IM-IV

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2018-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown